Wednesday, February 17, 2021

NIH funds study to evaluate remdesivir for COVID-19 in pregnancy

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

02/17/2021 09:15 AM EST

The study will be conducted at 17 sites in the continental United States and Puerto Rico.

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

No comments:

Post a Comment

🐤 Albemarle Stock: Strong Fundamentals vs. Lithium Volatility

Albemarle Corporation (NYSE: ALB) is a global leader in the production of basic materials for a diverse range of industries, including en...